Insurers Must Ditch Short-term Focus On Alzheimer's And Go For Zentara's Revolutionary Regime
- Posted on February 25, 2025
- By International Business Times
- 6 Views

Insurers Must Ditch Short-term Focus On Alzheimer's And Go For Zentara's Revolutionary Regime

Zentara, a groundbreaking new company, is pushing to steer the conversation away from these ineffective tactics to cutting-edge AD prevention using affordable blood-based biomarkers.